A review of the relationship between the immune response, inflammation, oxidative stress, and the pathogenesis of sickle cell anaemia

FI Aboderin, T Oduola, GM Davison, OO Oguntibeju - Biomedicines, 2023 - mdpi.com
Sickle cell anaemia (SCD) is a life-threatening haematological disorder which is
predominant in sub-Saharan Africa and is triggered by a genetic mutation of the β-chain …

Cell and gene therapy for anemia: hematopoietic stem cells and gene editing

D Anurogo, N Yuli Prasetyo Budi, MH Thi Ngo… - International journal of …, 2021 - mdpi.com
Hereditary anemia has various manifestations, such as sickle cell disease (SCD), Fanconi
anemia, glucose-6-phosphate dehydrogenase deficiency (G6PDD), and thalassemia. The …

Macrophage metabolic rewiring improves heme-suppressed efferocytosis and tissue damage in sickle cell disease

R Sharma, A Antypiuk, SZ Vance… - Blood, The Journal …, 2023 - ashpublications.org
Sickle cell disease (SCD) is hallmarked by an underlying chronic inflammatory condition,
which is contributed by heme-activated proinflammatory macrophages. Although previous …

[HTML][HTML] Thromboinflammatory mechanisms in sickle cell disease–challenging the hemostatic balance

N Conran, EV De Paula - Haematologica, 2020 - ncbi.nlm.nih.gov
Sickle cell disease (SCD) is an inherited hemoglobinopathy that is caused by the presence
of abnormal hemoglobin S (HbS) in red blood cells, leading to alterations in red cell …

HbS promotes TLR4-mediated monocyte activation and proinflammatory cytokine production in sickle cell disease

S Allali, R Rignault-Bricard… - Blood, The Journal …, 2022 - ashpublications.org
Monocytes are considered crucial actors of inflammation in sickle cell disease (SCD), being
responsible for an increased production of proinflammatory cytokines such as tumor …

[HTML][HTML] The molecular basis for the prothrombotic state in sickle cell disease

AS Shet, MA Lizarralde-Iragorri, RP Naik - Haematologica, 2020 - ncbi.nlm.nih.gov
The genetic and molecular basis of sickle cell disease (SCD) has long been characterized
but the pathophysiological basis has not been entirely defined. How a red cell hemolytic …

Complement in sickle cell disease and targeted therapy: I know one thing, that I know nothing

A Tampaki, E Gavriilaki, C Varelas, A Anagnostopoulos… - Blood Reviews, 2021 - Elsevier
Sickle cell disease (SCD) is a common inherited clinical syndrome, characterized by the
presence of hemoglobin S. Anemia, susceptibility to infections and episodes of vaso …

Inflammation and autoimmunity are interrelated in patients with sickle cell disease at a steady-state condition: implications for vaso-occlusive crisis, pain, and sensory …

W Li, AQ Pucka, C Debats, BA Reyes, F Syed… - Frontiers in …, 2024 - frontiersin.org
This study aimed to comprehensively analyze inflammatory and autoimmune characteristics
of patients with sickle cell disease (SCD) at a steady-state condition (StSt) compared to …

Mouse models of sickle cell disease: imperfect and yet very informative

S Kamimura, M Smith, S Vogel, LEF Almeida… - Blood Cells, Molecules …, 2024 - Elsevier
The root cause of sickle cell disease (SCD) has been known for nearly a century, however,
few therapies to treat the disease are available. Over several decades of work, with …

Inflammatory status in pediatric sickle cell disease: Unravelling the role of immune cell subsets

S Marchesani, V Bertaina, O Marini… - Frontiers in Molecular …, 2023 - frontiersin.org
Introduction: The mutation of the beta-globin gene that causes sickle cell disease (SCD)
results in pleiotropic effects, such as hemolysis and vaso-occlusive crisis that can induce …